In an effort to assist national blood services in the development of plans to respond to any emerging infectious threats, as far as the sufficiency or safety of the blood supply are concerned, the World Health Organisation (WHO) produced in 2019 a special document, which discusses the elements that ...
Read More »
The biotech company Novavax announced today that it has identified an “ideal” coronavirus vaccine candidate — and is set to launch the first clinical human trial in mid-May. The candidate, NVX-CoV2373, proved its ability to produce immune responses and high levels of antibodies against COVID-19 in pre-clinical animal trials, the Gaithersburg, ...
Read More »
Given the unprecedented global public health crisis brought on by the COVID-19 pandemic, TIF announces that the celebrations of the International Thalassaemia Day 2020 on the 8th of May, including all the Federation’s activities that were initially programmed, are rescheduled for Monday, 8 September 2020. TIF strongly urges its members ...
Read More »
During these difficult and challenging times the coronavirus (COVID-19) pandemic is creating at a global level, individuals with underlying medical conditions, such as blood disorders, heart disease, chronic liver disease, endocrine disorders or patients with a compromised immune system, may face an increased risk of COVID-19 infection, according to the ...
Read More »
The coronavirus presents many uncertainties, and none of us can completely eliminate the risk of getting infected with COVID-19. Nevertheless, one thing we can do is eat as healthy as possible! In addition to the well-known personal hygiene and preventive measures against the new coronavirus (COVID-19), we can also follow ...
Read More »
TIF‘s Renzo Galanello Fellowship Programme is back again in 2020!
Read More »
TIF
